Creative Diagnostics' research team takes advantage of mouse models to study a variety of influenza A virus strains, including H9N2, H1N1 and H3N2. The portfolio offers customized and standard preclinical services to evaluate pathogenesis, humoral responses, and protective efficacy induced by wild-type influenza A viruses or influenza vaccines using mouse infection models. Mouse models offered by Creative Diagnostics include but are not limited to H9N2 Avian Influenza Mouse Model, H1N1 Mouse Model, Pdm H1N1 Mouse Model and H3N2 Mouse Model.
Creative Diagnostics specializes in providing state-of-the-art mouse models of influenza A virus that allow comprehensive assessment of the impact of test compounds on the pathogenicity and transmissibility of influenza A strains. These innovative mouse models provide valuable insights into virus-host interactions, revealing transmission dynamics and the impact of influenza A on morbidity and mortality. Additionally, Creative Diagnostics provides valuable data on viral disease progression, histology, immunohistochemistry, immunoassays, flow cytometry, cellular infiltration, cytokines, viral titers, LD50 studies, and vaccine/treatment efficacy.
Location
New York Shirley, New York 11967
Number of Employees
1-10